Both in Pharmaceuticals
Actinium Pharmaceuticals vs Gain Therapeutics
Over the past year ATNM returned +1.4% and GANX returned −37.5%; their daily moves had a correlation of 0.19.
ATNM +1.4% GANX −37.5%Growth of $1, one year, split-adjusted
| Metric | ATNM | GANX |
|---|---|---|
| Price | $1.40 | $1.15 |
| Market cap | $44.0M | $50.2M |
| Today | −2.10% | +1.77% |
| 1 month | +16.7% | −32.0% |
| 6 months | +11.1% | −38.5% |
| Year to date | +2.9% | −64.3% |
| 1 year | −2.1% | −41.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 79.7% | — |
| P/E (TTM) | 3.9× | — |
| Price / sales | 1.3× | — |
| Net cash | $36.5M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.6% | 64.2% |
| Short % of float | 2.0% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).